5 May 2026
LIFEPharma launches AED 100 million, region-first gene therapy initiative targeting rare inherited blood disorders
EQUIGENE Therapeutics, a new spin-off biotech anchored by world-class hematology experts, marks a pivotal step in the UAE's advanced therapeutics ambitions Abu Dhabi, 5 May 2026 : LIFEPharma, the UAE's only USFDA‑approved pharmaceutical manufacturer and a part of VPS Health today announced ...
Read Full Article →